TRPM7-IN-1
TRPM7-IN-1 (compound SUD), a benzoylurea derivative, is an effective TRPM7 inhibitor. TRPM7-IN-1 induces cell cycle arrest and apoptosis, decreases the migration of MCF-7 and BGC-823 cells. TRPM7-IN-1 decreases vimentin expression and increases E-cadherin expression. TRPM7-IN-1 potentially reduces the TRPM7-like current and decreases TRPM7 expression through the PI3K/Akt signaling pathway. TRPM7-IN-1 is a potential agent to suppress the metastasis of breast and gastric cancer by inhibiting TRPM7 expression and function[1].
Product Specifications
CAS Number
1909225-07-5
UNSPSC
12352211
Target
Akt; Apoptosis; PI3K; TRP Channel
Type
Reference compound
Related Pathways
Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/trpm7-in-1.html
Purity
98.83
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC(C1=CC=CC=C1N(C)C)=O)NC2=CC=C(OC3=NC(C)=CC(C)=N3)C(C)=C2
Molecular Formula
C23H25N5O3
Molecular Weight
419.48
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Akt; PI3K; TRPM7
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Rat Thrombin Activatable Fibrinolysis Inhibitor (TAFI) ELISA Kit
Rat Thrombin Activatable Fibrinolysis Inhibitor (TAFI) ELISA Kit
2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-bromopropan-2-ol
